Company intelligence / Profile preview

Custom Biologics

Toronto, Ontario, Canadacustombiologics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Custom Biologics does not develop its own therapeutics but provides GLP/GxP-compliant bioanalytical assay development, validation, and testing services supporting the functional characterization, potency/bioactivity assessment, pharmacokinetics, immunogenicity studies for biologic drugs, vaccines, cell/gene therapies at all stages of drug development. It has supported over 200 pre-clinical/CMC and clinical immunogenicity studies for more than 125 clients worldwide over its >20-year history.

Therapeutic areas: Other
Modalities: Biologics (large molecules)Small moleculesVaccinesCell therapiesGene therapiesOncolytic virusesNucleic acid-based vaccines
Industry: Contract Research Organization

Beyond the preview

Go deeper on Custom Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Custom Biologics.

Explore the full profile